Abiopharma

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001839882-26-039413 <b>Size:</b> 293 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001839882-26-039411 <b>Size:</b> 340 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0000950103-26-012154 <b>Size:</b> 336 KB

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy Back Notice

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Announcement of Final Results of Private Exchange Offer for CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

Nocera Clears Every Open Nasdaq Listing Matter With Stockholders Equity of $5.4 Million - More Than Double the Required Minimum - and Turns Full Attention to Acquisitions

Reborn Coffee Signs Strategic Memorandum of Understanding with The Mighty Oak Inc. to Expand U.S. Produce Sales Across H Mart, Hannam Chain and GW Supermarket

(99% Neutral) CLASSOVER HOLDINGS, INC. (KIDZW) Files Form 8-K

(30% Negative) ADAGIO MEDICAL HOLDINGS, INC. (ADGM) Reports Q3 2026 Financial Results

(85% Positive) PDS BIOTECHNOLOGY CORP (PDSB) Announces Enrollment Update for opportunities Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) ULTRAGENYX PHARMACEUTICAL INC. (RARE) Announces Regulatory Update

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer

The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination